2023-505030-99-00撤回1 期
First administration in healthy volunteers of a single and increasing dose of a new molecule for the treatment of brain diseases
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Chief Medical Officer Dr Florent Perin-Dureau
Scientific
Rest Therapeutics
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A phase 1 clinical pharmacological study with a single oral dose of KAG-308JPRN-UMIN000011878Kaken Pharmaceutical Co., LTD60
已完成
1 期
A Trial in Healthy Participants to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRAX-944Essential TremorNeurological - Other neurological disordersACTRN12620000675921Praxis Precision Medicines24
已完成
不适用
A Phase I, open label trial in healthy subjects to evaluate the central nervous receptor occupancy of pipamperone at the 5-HT2A and D2 receptor by means of Positron Emission Tomography.major depressive disorder10027946depressionNL-OMON34843PharmaNeuroBoost NV10
已完成
不适用
A phase 1 study in healthy volunteers to determine the dermatopharmacokinetics of topically applied diclofenac in combination with the novel penetration enhancer Tocopheryl Phosphate Mixture (TPM), compared with Votaren(registered trademark) gelMuscular or joint pain relief in healthy volunteers currently experiencing no painOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12609000505202Phosphagenics Limited24
已完成
不适用
A phase I, open label clinical trial in healthy volunteers, to assess and characterize the effect of FIRTECH infrared patch on tissue perfusion, oxygenation and local microcirculation.muscle strainNL-OMON50771Sanofi Aventis Groupe20